Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v2-FR
Language English French
Date Updated 2019-07-23 2019-07-19
Drug Identification Number 02399334 02399334
Brand name CALCITRIOL INJECTION USP CALCITRIOL INJECTION USP
Common or Proper name CALCITRIOL INJECTION USP CALCITRIOL INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients CALCITRIOL CALCITRIOL
Strength(s) 1MCG 1MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 25 AMPOULES 25 AMPOULES
ATC code A11CC A11CC
ATC description VIT A AND D, INCL COMBINATIONS OF THE TWO VIT A AND D, INCL COMBINATIONS OF THE TWO
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-07-22 2019-07-22
Estimated end date 2019-09-16 2019-09-16
Actual end date
Shortage status Actual shortage Anticipated shortage
Company comments Remaining stock available to hospitals at 50% allocation at McKesson starting July 22nd. Remaining stock available to hospitals at 50% allocation at McKesson starting July 22nd.
Health Canada comments